A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Rabeprazole Impurity 11 - Request Quote

Picture of Rabeprazole Impurity 11

Rabeprazole Impurity 11

SZ CAT No:SZ-R006046
CAS No
NA
Mol.F.
C17H19N3O5S
Mol.Wt.
377.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Rabeprazole Impurity 11 is chemically 2-((4-(3-Methoxypropoxy)-3-methyl-1-oxidopyridin-2-yl)sulfinyl)-1H-benzo[d]imidazole 1-oxide. Rabeprazole Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Rabeprazole Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rabeprazole.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Rabeprazole Impurity 11

Purchase Rabeprazole Impurity 11

Rabeprazole Impurity 11 suppliers

Rabeprazole Impurity 11 manufacturers

Rabeprazole Impurity 11 price

Order Rabeprazole Impurity 11

Enquire Rabeprazole Impurity 11

Rabeprazole Impurity 11 cost

Rabeprazole Impurity 11 Supplier

Rabeprazole Impurity 11 Distributor

Rabeprazole Impurity 11 for Method Validation

Rabeprazole Reference Standard

Rabeprazole Impurity 11 for ANDA Filing

Rabeprazole Impurity 11 for Forced Degradation Studies

Rabeprazole Impurity 11 Identification Standards

Rabeprazole Impurity 11 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,